Abstract
For a long time markers that can detect a malignant cell transformation as early as possible have been sought. Substances which have been discovered are known as tumor markers. Stem cell factor (SCF) and interleukin 3 (IL-3) are members of a group of glycoprotein growth factors called hematopoietic cytokines (HCs). These factors take part in the regulation of developmental processes of hematopoietic progenitor cells and it was proved that HCs can be produced by different cancer cells, including colorectal cancer. The aim of this study was to investigate a potential role for SCF and IL-3 as tumor markers for colorectal cancer. We compared the serum levels of SCF and IL-3 in colorectal cancer patients with those in healthy subjects (control group) and commonly accepted tumor markers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9). We defined the diagnostic sensitivity, specificity, positive predictive value, negative predictive value, and receiver-operating characteristics (ROC) curve of tested substances. SCF and IL-3 were determined using enzyme-linked immunosorbent assay (ELISA). CEA and CA 19-9 were measured by microparticle enzyme immunoassay. The serum levels of HCs and tumor markers were investigated in 75 patients with colorectal cancer and in 40 healthy subjects. There were significant differences in the level of circulating SCF and IL-3 in the colorectal cancer patients compared to the control group. Moreover, the diagnostic sensitivity of SCF was higher than the sensitivity of CEA and CA 19-9. The SCF area under the ROC curve was larger than the IL-3 area but smaller than the CEA and CA 19-9 areas. The diagnostic specificities of cytokines were lower than those of tumor markers, but the combined use of cytokines and tumor markers increased the diagnostic values. The highest values of diagnostic parameters were observed for the combined use of SCF and CA 19-9. These results suggest a potential role for SCF and IL-3 as tumor markers for colorectal cancer, especially in combination with CEA or CA 19-9.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Refrences
Ahmad NA, Kochman Ml, Ginsberg GG: Endoscopic ultrasound and endoscopic mucosal resection for rectal cancers and villous adenomas. Hematol Oncol Clin N Am 16:897–906, 2002
Negm RS, Verma M, Srivastava S: The promise of biomarkers in cancer screening and detection. Trends Mol Med 8:288–293, 2002
Smith MA, Court El, Smith JG: Stem cell factor: laboratory and clinical aspects. Blood Rev 15:191–197, 2001
Berdel WE, Denhauser-Riedl S, Steinhauser G, Winton: Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 73:80-83, 1989
Trutmann M, Terracciano l, Noppen C, Kloth J, Kaspar M, Peterli R, Tondelli P, Schaefer Ch, Zajac P, Heberer M, Spagnoli GC: GM-CSF gene expression and protein production in human colorectal cell lines and clinical tumor specimens. Int J Cancer 77:378–385, 1998
Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett lG, Broudy VC: Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80:374–380, 1992
Dunlop RJ, Campbell CW: Cytokines and advanced cancer. J. Pain Symptom Manage 20:214–232, 2000
McDermott RS, Deneux l, Mosseri V, Vedrenne J, Clough K, Fourquet A, Rodriguez J, Cosset JM, Sastre X, Beuzeboc Ph, Pouillart P, Scholl SM: Circulating macrophage colony stimulating factor as a marker of tumor progression. E Cytokine Network 13:121–127, 2002
Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer 79:40–46, 1999
Lahm H, Amstad P, Yilmaz A, Borbenyi Z, Wyniger J, Fischer JR, Suardet l, Givel JC, Odartchenko N: Interleukin 4 down-regulates expression of c-kit and autocrine stem cell factor in human colorectal carcinoma cells. Cell Growth Diff 6:1111–1118, 1995
Lahm H, Wyniger J, Hertig S, Yilmaz A, Fischer J, Givel JC, Odartchenko N: Secretion of bioactive granulocyte-macrophage colony-stimulating factor by human colorectal carcinoma cells. Cancer Res 54:3700–3702, 1994
Mroczko B., Szmitkowski M., Okulczyk B: Granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in colorectal cancer patients. Clin Chem Lab Med 40:351–355, 2002
Mroczko B, Szmitkowski M, Okulczyk B: Hematopoietic growth factors in colorectal cancer patients. Clin Chem lab Med 41:646–651, 2003
Mroczko B, Szmitkowski M, Wereszczynska-Siemiatkowska U, Jurkowska G: Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer. Clin Chem Lab Med 42:256–260, 2004
Fleming ID, Cooper JS, Henson DE, Hutter VP, Kennedy BJ, Murphy GP, O’Sullivan B, Sobin lH, Yarbro JW: Colon and Rectum. AJCC Cancer Staging Manual. New York, Lippincott–Raven, 1997
Jass JR, Sobin LH: Definition and explanatory notes. Large intestine. Histological Typing of Intestinal Tumors. New York, Springer-Verlag, 1989
Kairisto V, Virtanen A, Uusipaikka E, Voipio-Pulkki lM, Nanto V, Peltola O, Irjala K: Method for determining reference changes from patients serial data: example of cardiac enzymes. Clin Chem 39:2298–2304, 1993
Gongoll S, Peters G, Mengel M, Piso P, Klempnauer J, Kreipe H, Wasielewski R: Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 123:1478–1484, 2002
Lynch JP, Hoops TC: The genetic pathogenesis of colorectal cancer. Hematol Oncol Clin N Am 16:775–810, 2002
Lindblom A, liljegren A: Tumour markers in malignancies. BMJ 320:424–427, 2000
Esposito I, Kleeff J, Bischoff SC, Fischer l, Collecchi P, Iorio M, Bevilacqua G, Buchler MW, Friess H: The stem cell factor-c-kit system and mast cells in human pancreatic cancer. Lab Invest 82:1481–1492, 2002
Mroczko B, Szmitkowski M, Niklinski J: Stem cell factor and granulocyte-macrophage–colony stimulating factor as candidates for tumour markers for non-small-cell lung cancer. Clin Chem lab Med 37:959–962, 1999
Mroczko B, Szmitkowski M, Niklinski J: Granulocyte-colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer. Clin Chem Lab Med 39:374–379, 2001
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mroczko, B., Szmitkowski, M., WereszczyńSka-Siemiątkowska, U. et al. Stem Cell Factor (SCF) and Interleukin 3 (IL-3) in the Sera of Patients with Colorectal Cancer. Dig Dis Sci 50, 1019–1024 (2005). https://doi.org/10.1007/s10620-005-2697-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2697-3